The effectivness of camel milk in autism spectrum disorders

Completed

• Conditions: Autism spectrum disorders; Mental and Behavioural Disorders; Pervasive developmental disorders

• Registration Number: ISRCTN87863054
• Lead Sponsor: King Abdul Aziz City for Science and Technology (KACST) (Saudi Arabia)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-04-12
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Children with autism spectrum disorders (ASD) confirmed by Autism Diagnostic Observation Schedule (ADOS) and Developmental, Dimensional and Diagnostic Interview (3DI)
2. Aged between 4 and 15 years, either sex
3. All simplex cases

Exclusion Criteria

1. Fragile X gene study
2. Tuberous sclerosis
3. Angleman syndrome
4. Other serious neurological conditions (e.g., seizures)
5. Psychiatric (e.g., bipolar disorder) or known medical conditions

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Less allergy <br>2. Increased attention<br>3. Increased concentration<br> <br>Outcomes assessed at baseline, 3 and 6 months, using the following tools:<br>1. Parent Questionnaire <br>2. Social Responsiveness Scale (SRS)<br>3. Childhood Autism Rating Scale (CARS)<br>4. Autism Treatment Evaluation Checklist (ATEC)

Secondary Outcome Measures

Name	Time	Method
1. Improve general health<br>2. Improve social relation<br>3. Improve academic performance <br><br>Outcomes measures immediately following intervention, and 3 and 6 months afterwards.